4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001662579-25-000020
Chief Legal Officer gave up 5,049 shares (to pay taxes)
- Chief Legal Officer acquired 56,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Siegel Jolie · Chief Legal Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-02-13 | Shares withheld for taxes : show line 1 in the form | −2,135 | $3.20 | $6,832 | 54,353 | D |
| 2025-02-14 | Grant or award : show line 2 in the form | +56,500 | 110,853 | D | ||
| 2025-02-14 | Shares withheld for taxes : show line 3 in the form | −2,914 | $3.18 | $9,267 | 107,939 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-14 | Grant or award : show line 4 in the form Stock Option (Right to Buy) | +84,700 | 84,700 | D |
Loading xslF345X05/wk-form4_1739915720.xml…